101 related articles for article (PubMed ID: 8622011)
1. Major toxicity of cisplatin, fluorouracil, and leucovorin following chemoradiotherapy in patients with nasopharyngeal carcinoma.
Celik I; Kars A; Ozyar E; Tekuzman G; Atahan L; Firat D
J Clin Oncol; 1996 Mar; 14(3):1043-4. PubMed ID: 8622011
[No Abstract] [Full Text] [Related]
2. Neoadjuvant chemotherapy with continuous infusion of cisplatin and 5-fluorouracil, with or without leucovorin, for locally advanced nasopharyngeal carcinoma.
Fonseca E; Cruz JJ; Rodríguez CA; Gómez-Bernal A; Martín G; Sánchez P; Nieto A; Soria P; Vega MJ; Muñoz A; Pardal JL
J Infus Chemother; 1996; 6(4):217-20. PubMed ID: 9229319
[TBL] [Abstract][Full Text] [Related]
3. A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma.
Chua DT; Sham JS; Au GK
Head Neck; 2004 Feb; 26(2):118-26. PubMed ID: 14762880
[TBL] [Abstract][Full Text] [Related]
4. Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.
Schwarz LR
Cancer; 1996 Aug; 78(3):566-7. PubMed ID: 8697406
[No Abstract] [Full Text] [Related]
5. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin and fluorouracil concurrent to radiotherapy in nasopharyngeal cancer: is the schedule compatible?
Licitra L; Bossi P; Locati L; Zunino F
J Clin Oncol; 2004 Jan; 22(2):377; author reply 377-8. PubMed ID: 14722048
[No Abstract] [Full Text] [Related]
7. Concurrent chemoradiotherapy with carboplatin followed by carboplatin and 5-fluorouracil in locally advanced nasopharyngeal carcinoma.
Dechaphunkul T; Pruegsanusak K; Sangthawan D; Sunpaweravong P
Head Neck Oncol; 2011 Jun; 3():30. PubMed ID: 21639934
[TBL] [Abstract][Full Text] [Related]
8. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma.
Chan AT; Teo PM; Leung TW; Leung SF; Lee WY; Yeo W; Choi PH; Johnson PJ
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):569-77. PubMed ID: 7558945
[TBL] [Abstract][Full Text] [Related]
9. Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma.
Rodriguez-Galindo C; Wofford M; Castleberry RP; Swanson GP; London WB; Fontanesi J; Pappo AS; Douglass EC
Cancer; 2005 Feb; 103(4):850-7. PubMed ID: 15641027
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and feasibility of cisplatin-based concurrent chemoradiotherapy for nasopharyngeal carcinoma.
Demizu Y; Sasaki R; Soejima T; Maruta T; Okamoto Y; Yamada K; Yoden E; Ejima Y; Ota Y; Ishida H; Nibu K; Sugimura K
Jpn J Clin Oncol; 2006 Oct; 36(10):620-5. PubMed ID: 16905756
[TBL] [Abstract][Full Text] [Related]
11. Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma.
Benasso M; Sanguineti G; D'Amico M; Corvò R; Ricci I; Numico G; Guarneri D; Vitale V; Pallestrini E; Santelli A; Rosso R
Br J Cancer; 2000 Dec; 83(11):1437-42. PubMed ID: 11076650
[TBL] [Abstract][Full Text] [Related]
12. Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma.
Hong RL; Ting LL; Ko JY; Hsu MM; Sheen TS; Lou PJ; Wang CC; Chung NN; Lui LT
J Clin Oncol; 2001 Dec; 19(23):4305-13. PubMed ID: 11731513
[TBL] [Abstract][Full Text] [Related]
13. A prospective, randomized, multi-center trial to investigate Actovegin in prevention and treatment of acute oral mucositis caused by chemoradiotherapy for nasopharyngeal carcinoma.
Wu SX; Cui TT; Zhao C; Pan JJ; Xu BY; Tian Y; Cui NJ
Radiother Oncol; 2010 Oct; 97(1):113-8. PubMed ID: 20826029
[TBL] [Abstract][Full Text] [Related]
14. Severe reaction after chemoradiotherapy of nasopharyngeal carcinoma with collagen disease.
Hareyama M; Nagakura H; Tamakawa M; Hyodo K; Asakura K; Horikoshi T; Oouchi A; Shido M; Morita K
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):971. PubMed ID: 7591915
[No Abstract] [Full Text] [Related]
15. Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer.
Bae WK; Hwang JE; Shim HJ; Cho SH; Lee JK; Lim SC; Chung WK; Chung IJ
Cancer Chemother Pharmacol; 2010 Feb; 65(3):589-95. PubMed ID: 19830427
[TBL] [Abstract][Full Text] [Related]
16. Treatment results of alternating chemoradiotherapy for nasopharyngeal cancer using cisplatin and 5-fluorouracil--a phase II study.
Fuwa N; Shikama N; Hayashi N; Matsuzuka T; Toita T; Yuta A; Oonishi H; Kodaira T; Tachibana H; Nakamura T; Daimon T
Oral Oncol; 2007 Oct; 43(9):948-55. PubMed ID: 17257880
[TBL] [Abstract][Full Text] [Related]
17. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
Chan SH; Ng WT; Kam KL; Lee MC; Choi CW; Yau TK; Lee AW; Chow SK
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1335-42. PubMed ID: 18922648
[TBL] [Abstract][Full Text] [Related]
18. Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors.
Lee AW; Ng WT; Hung WM; Choi CW; Tung R; Ling YH; Cheng PT; Yau TK; Chang AT; Leung SK; Lee MC; Bentzen SM
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1121-8. PubMed ID: 18723296
[TBL] [Abstract][Full Text] [Related]
19. Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma.
Lin JC; Jan JS; Chen KY; Hsu CY; Liang WM; Wang WY
Head Neck; 2003 Jun; 25(6):438-50. PubMed ID: 12784235
[TBL] [Abstract][Full Text] [Related]
20. Alternating chemoradiotherapy for nasopharyngeal cancer using cisplatin and 5-fluorouracil: a preliminary report of phase II study.
Fuwa N; Kano M; Toita T; Shikama N; Kodaira T; Matsumoto A; Kamata M; Furutani K; Tatibana H
Radiother Oncol; 2001 Dec; 61(3):257-60. PubMed ID: 11730994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
